HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fusion imaging with contrast-enhanced ultrasonography for evaluating the early therapeutic efficacy of radiofrequency ablation for small hypervascular hepatocellular carcinomas with iso-echoic or unclear margins on conventional ultrasonography.

AbstractPURPOSE:
We evaluated the efficacy of fusion imaging combining contrast-enhanced ultrasonography (CEUS) images and arterial phase contrast-enhanced CT (CECT) or hepatobiliary phase magnetic resonance imaging with gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid (EOB-MRI) images for the early evaluation of the effectiveness of radiofrequency ablation (RFA) for small hypervascular hepatocellular carcinoma (HCC) with iso-echoic or unclear margins on conventional US.
METHODS:
Forty HCCs (22 iso-echoic and 18 unclear margin lesions) with mean diameters of 13.7 mm were treated using RFA under the guidance of fusion imaging with CEUS. The adequacy of RFA was evaluated using fusion imaging with CEUS 1 day after RFA. CECT or EOB-MRI was performed 1 month after RFA. We reviewed the images obtained using both modalities.
RESULTS:
When the 1-month CECT or EOB-MRI scans were used as the reference standard, the sensitivity, specificity, and accuracy of the 1-day fusion imaging for the diagnosis of the adequate ablation of these HCCs were 97, 100, and 98%, respectively; the kappa value for the agreement between the findings using the two modalities was 0.655.
CONCLUSION:
Fusion imaging with CEUS appears to be a useful method for the early evaluation of the efficacy of RFA for the treatment of HCCs with iso-echoic or unclear margins on conventional US.
AuthorsShuhei Nishigori, Kazushi Numata, Kuniyasu Irie, Hiroyuki Fukuda, Makoto Chuma, Shin Maeda
JournalJournal of medical ultrasonics (2001) (J Med Ultrason (2001)) Vol. 45 Issue 3 Pg. 405-415 (Jul 2018) ISSN: 1613-2254 [Electronic] Japan
PMID29362966 (Publication Type: Journal Article)
Chemical References
  • Contrast Media
  • gadolinium ethoxybenzyl DTPA
  • Gadolinium DTPA
Topics
  • Aged
  • Aged, 80 and over
  • Carcinoma, Hepatocellular (diagnostic imaging, surgery)
  • Catheter Ablation
  • Contrast Media
  • Disease Progression
  • Female
  • Follow-Up Studies
  • Gadolinium DTPA
  • Humans
  • Liver (diagnostic imaging, surgery)
  • Liver Neoplasms (diagnostic imaging, surgery)
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Multimodal Imaging (methods)
  • Sensitivity and Specificity
  • Tomography, X-Ray Computed
  • Treatment Outcome
  • Tumor Burden
  • Ultrasonography (methods)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: